Bejerui key facts
- Manufacturer of biomedical imaging instruments designed to enable non-invasive analysis and monitoring of living cells and blood samples.
- Notable investors include Lingyi Capital, Fan Zhuo Capital, Galileo Venture.
- Status: Privately Held (backing).
Who backs Bejerui
3- ·Watch Bejerui: the Monday email on marks, rounds and moves
Bejerui funding rounds
No funding rounds for Bejerui are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Bejerui investors
3 investors are on record for Bejerui, including Lingyi Capital, Fan Zhuo Capital and Galileo Venture.
About Bejerui
Manufacturer of biomedical imaging instruments designed to enable non-invasive analysis and monitoring of living cells and blood samples. The company offers label-free quantitative phase imaging microscopes with integrated artificial intelligence analysis, automated imaging, and environmental control, enabling life science researchers and healthcare professionals to obtain accurate cellular insights and support early disease detection.
- Sector
- Healthcare
- HQ
- Shenzhen, China
- Founded
- 2019
- Website
- bayjayray.cn/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.
Bejerui doesn't have a valuation on record yet — one is published once a priced round, a reported valuation, fund marks, or secondary prints surface in our sources. The rest of the record below builds toward it.